By sustaining TREX2 expression, NSUN2 limits cytosolic dsDNA accumulation and suppresses cGAS/STING-mediated innate immune responses, thereby facilitating tumor progression and resistance to anti-PD-L1 therapy (80). The gene discussed is NSUN2; the disease is neoplasm.